Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Danhof

Showing results (71-80 of 250) with videos related to

Pageof 25
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1993
Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectivesM Danhof, J W Mandema, A Hoogerkamp, et al.
Clinical Pharmacology and Therapeutics|August 7, 2009
From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugsG Santen, E van Zwet, M Danhof, et al.
Pharmaceutical Research|October 8, 2013
Semi-mechanistic modelling of the analgesic effect of gabapentin in the formalin-induced rat model of experimental painA Taneja, I F Troconiz, M Danhof, et al.
Pharmaceutical Research|July 1, 1989
Relationship between receptor occupancy at 37 degrees C and the anticonvulsant effect of flunitrazepam in ratsM Hollander-Jansen, J Dingemanse, M W Langemeijer, et al.
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1988
Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measureJ Dingemanse, F A Sollie, D D Breimer, et al.
British Journal of Pharmacology|July 6, 2000
Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levelsA Cleton, B A Altorf, R A Voskuyl, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2000
Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationshipA Cleton, B A Altorf, R A Voskuyl, et al.
British Journal of Pharmacology|July 19, 2016
Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studiesV F S Dubois, E Casarotto, M Danhof, et al.
Haemostasis|January 1, 1992
Pharmacokinetic considerations on Orgaran (Org 10172) therapyM Danhof, A de Boer, H N Magnani, et al.
Pharmacology|January 1, 1979
Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in manM Danhof, E de Groot-van der Vis, D D Breimer
Pageof 25

Showing results (71-80 of 250) with videos related to

Sort By:
Pageof 25
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1993
Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectivesM Danhof, J W Mandema, A Hoogerkamp, et al.
Clinical Pharmacology and Therapeutics|August 7, 2009
From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugsG Santen, E van Zwet, M Danhof, et al.
Pharmaceutical Research|October 8, 2013
Semi-mechanistic modelling of the analgesic effect of gabapentin in the formalin-induced rat model of experimental painA Taneja, I F Troconiz, M Danhof, et al.
Pharmaceutical Research|July 1, 1989
Relationship between receptor occupancy at 37 degrees C and the anticonvulsant effect of flunitrazepam in ratsM Hollander-Jansen, J Dingemanse, M W Langemeijer, et al.
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1988
Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measureJ Dingemanse, F A Sollie, D D Breimer, et al.
British Journal of Pharmacology|July 6, 2000
Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levelsA Cleton, B A Altorf, R A Voskuyl, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2000
Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationshipA Cleton, B A Altorf, R A Voskuyl, et al.
British Journal of Pharmacology|July 19, 2016
Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studiesV F S Dubois, E Casarotto, M Danhof, et al.
Haemostasis|January 1, 1992
Pharmacokinetic considerations on Orgaran (Org 10172) therapyM Danhof, A de Boer, H N Magnani, et al.
Pharmacology|January 1, 1979
Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in manM Danhof, E de Groot-van der Vis, D D Breimer
Pageof 25